Sept 12 (Reuters) - AFT Pharmaceuticals Ltd AFT.NZ :
* Company is estimating it will sell approximately 72 million tablets worldwide
in FY 2017
* Provides FY 2017 sales forecast for patented product, maxigesic
* Patented nasosurf nebuliser "on track to file first regulatory filing with US
food and drug administration this calendar year"
* Source text